Literature DB >> 12915082

Adverse events associated with intravenous phenytoin in children: a prospective study.

Richard E Appleton1, Andrea Gill.   

Abstract

A prospective study was undertaken to assess the type and frequency of adverse side-effects following the use of intravenous phenytoin in children. Twenty-two children received a total of 100 doses over a 10-month period. Six patients (27%) experienced one or more side-effects, including extravasation of the drug, hypotension and cardiac arrhythmia. No patient developed skin necrosis, including the 'purple glove syndrome'. Recovery from all adverse side-effects was spontaneous and complete. It is possible that some or all of these side-effects may have been caused by an excessive rate of infusion of phenytoin or the saline 'flush' following administration of the drug. The overall frequency of side-effects was perhaps less than expected.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915082     DOI: 10.1016/s1059-1311(02)00338-2

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  8 in total

Review 1.  Levetiracetam versus phenytoin for seizure prophylaxis in brain injured patients: a systematic review and meta-analysis.

Authors:  Anis Chaari; Alaa Sayed Mohamed; Karim Abdelhakim; Vipin Kauts; William Francis Casey
Journal:  Int J Clin Pharm       Date:  2017-08-05

2.  Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.

Authors:  Richard E Appleton; Naomi Ea Rainford; Carrol Gamble; Shrouk Messahel; Amy Humphreys; Helen Hickey; Kerry Woolfall; Louise Roper; Joanne Noblet; Elizabeth Lee; Sarah Potter; Paul Tate; Nadia Al Najjar; Anand Iyer; Vicki Evans; Mark D Lyttle
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

Review 3.  Cardiovascular adverse effects of phenytoin.

Authors:  B Guldiken; J Rémi; Soheyl Noachtar
Journal:  J Neurol       Date:  2015-12-08       Impact factor: 4.849

Review 4.  Pharmacotherapy for Status Epilepticus.

Authors:  Eugen Trinka; Julia Höfler; Markus Leitinger; Francesco Brigo
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

5.  Emergency treatment with levetiracetam or phenytoin in status epilepticus in children-the EcLiPSE study: study protocol for a randomised controlled trial.

Authors:  Mark D Lyttle; Carrol Gamble; Shrouk Messahel; Helen Hickey; Anand Iyer; Kerry Woolfall; Amy Humphreys; Naomi E A Bacon; Louise Roper; Franz E Babl; Stuart R Dalziel; Mary Ryan; Richard E Appleton
Journal:  Trials       Date:  2017-06-19       Impact factor: 2.279

6.  Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.

Authors:  Mark D Lyttle; Naomi E A Rainford; Carrol Gamble; Shrouk Messahel; Amy Humphreys; Helen Hickey; Kerry Woolfall; Louise Roper; Joanne Noblet; Elizabeth D Lee; Sarah Potter; Paul Tate; Anand Iyer; Vicki Evans; Richard E Appleton
Journal:  Lancet       Date:  2019-04-17       Impact factor: 79.321

7.  Clinical Efficacy and Safety of Injectable Levetiracetam Versus Phenytoin as Second-Line Therapy in the Management of Generalized Convulsive Status Epilepticus in Children: An Open-Label Randomized Controlled Trial.

Authors:  Nuzhat Noureen; Saadia Khan; Asim Khursheed; Imran Iqbal; Moallah Maryam; Syed Muhammad Sharib; Neeta Maheshwary
Journal:  J Clin Neurol       Date:  2019-10       Impact factor: 3.077

Review 8.  Optimal Management of Status Epilepticus in Children in the Emergency Setting: A Review of Recent Advances.

Authors:  Shrouk Messahel; Louise Bracken; Richard Appleton
Journal:  Open Access Emerg Med       Date:  2022-09-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.